VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

Completed

Conditions: Heparin-induced Thrombocytopenia

Interventions: Procedure: Blood Draw

First Posted Date: 2015-08-18

Last Posted Date: 2020-02-17

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 15

Registration Number: NCT02526485

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

FAMS Mobile Health Intervention for Diabetes Self-care Support

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Behavioral: REACH + FAMS
Behavioral: REACH
Behavioral: Helpline & A1c results

First Posted Date: 2015-06-25

Last Posted Date: 2019-11-27

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 512

Registration Number: NCT02481596

Locations: 🇺🇸
Federally Qualified Health Centers & Vanderbilt Primary Care Clinics, Nashville, Tennessee, United States

Treatment Alternatives in iSGS (NoAAC PR-02 Study)

Completed

Conditions: Idiopathic Subglottic Stenosis (iSGS)

Interventions: Procedure: Endoscopic dilation of subglottic stenosis
Procedure: Endoscopic resection of the stenosis
Procedure: Tracheal Resection

First Posted Date: 2015-06-25

Last Posted Date: 2021-10-28

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 1239

Registration Number: NCT02481817

Locations: 🇺🇸
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
🇺🇸
Harvard Medical School -Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

and more 38 locations

Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: 6 week aerobic exercise intervention
Drug: Placebo
Drug: Morphine
Drug: naloxone

First Posted Date: 2015-06-11

Last Posted Date: 2020-09-23

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 117

Registration Number: NCT02469077

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇺🇸
Rush University, Chicago, Illinois, United States

Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)

Phase 2

Completed

Conditions: Pseudohypoparathyroidism Type 1a
Albright Hereditary Osteodystrophy

Interventions: Drug: Theophylline

First Posted Date: 2015-06-04

Last Posted Date: 2017-06-26

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 6

Registration Number: NCT02463409

Locations: 🇺🇸
Vanderbilt Unversity, Nashville, Tennessee, United States

Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children

Not Applicable

Withdrawn

Conditions: Asthma

Interventions: Device: AccuPAP
Drug: Albuterol and Ipratropium Continuous Nebulizer

First Posted Date: 2015-06-01

Last Posted Date: 2020-11-13

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT02458482

Locations: 🇺🇸
Vanderbilt University Medical Center Monroe Carell Jr. Childrens Hospital Pediatric Emergency Department, Nashville, Tennessee, United States

New Tools for Assessing Fracture Risk

Not Applicable

Terminated

Conditions: Osteoporosis
Fracture Risk Assessment

Interventions: Device: Osteoprobe-Reference Point Indentation (RPI)
Radiation: Dual-energy X-ray absorptiometry (DXA) Scans
Radiation: MRI

First Posted Date: 2015-05-06

Last Posted Date: 2020-11-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 48

Registration Number: NCT02436356

Locations: 🇺🇸
Vanderbilt Univeristy Medical Center, Nashville, Tennessee, United States

Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

Phase 1

Recruiting

Conditions: Multiple System Atrophy
Orthostatic Hypotension
Autonomic Failure
Pure Autonomic Failure

Interventions: Other: Abdominal compression
Other: Sham abdominal compression
Drug: Placebo pill
Drug: midodrine

First Posted Date: 2015-04-29

Last Posted Date: 2024-03-26

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 29

Registration Number: NCT02429557

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

Completed

Conditions: Pseudohypoparathyroidism
Albright Hereditary Osteodystrophy

First Posted Date: 2015-04-08

Last Posted Date: 2019-11-13

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 39

Registration Number: NCT02411461

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Behavioral: REACH
Behavioral: Helpline and A1c results
Behavioral: REACH + FAMS

First Posted Date: 2015-04-06

Last Posted Date: 2020-08-17

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 512

Registration Number: NCT02409329

Locations: 🇺🇸
Federally Qualified Health Centers and Vanderbilt Primary Care Clinics, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy